CD160 (CD160) (Middle Region) Peptide
-
- Target See all CD160 products
- CD160
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CD160 antibody (Catalog #: ARP42342_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CD160
- Synonyms
- CD160 Peptide, RGD1563598 Peptide, BY55 Peptide, AU045688 Peptide, By55 Peptide, NK1 Peptide, NK28 Peptide, CD160 molecule Peptide, CD160 antigen Peptide, CD160 Peptide, Cd160 Peptide
- Background
-
CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predic
Alias Symbols: BY55, FLJ46513, NK1, NK28
Protein Size: 181 - Molecular Weight
- 20 kDa
- Gene ID
- 11126
- NCBI Accession
- NM_007053, NP_008984
- UniProt
- O95971
-